Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ampco-Pittsburgh | AP | Jan 24, 2025 | 2.68 | +0.37 |
Amphastar Pharmaceuticals | AMPH | Jan 24, 2025 | 36.50 | +0.30 |
Amphenol | APH | Jan 24, 2025 | 77.19 | -1.73 |
Amplify Energy | AMPY | Jan 24, 2025 | 5.49 | -3.85 |
Amplify Online Retail ETF | IBUY | Jan 24, 2025 | 67.57 | +0.28 |
Amplify Transformational Data Sharing ETF | BLOK | Jan 24, 2025 | 49.30 | +0.63 |
Amplitech Group | AMPG | Jan 24, 2025 | 1.93 | -1.03 |
Amplitude A | AMPL | Jan 24, 2025 | 11.38 | +1.07 |
Amprius Technologies | AMPX | Jan 24, 2025 | 3.64 | +8.01 |
AMREP | AXR | Jan 24, 2025 | 30.32 | -2.41 |
AMTD Digital ADR | HKD | Jan 24, 2025 | 2.73 | 0.00 |
AMTD Idea Group ADR | AMTD | Jan 24, 2025 | 1.04 | +2.87 |
Amtech Systems | ASYS | Jan 24, 2025 | 5.30 | -0.75 |
Amylyx Pharmaceuticals | AMLX | Jan 24, 2025 | 3.60 | +1.12 |
AN2 Therapeutics | ANTX | Jan 24, 2025 | 1.25 | 0.00 |
Analog Devices | ADI | Jan 24, 2025 | 217.37 | -4.81 |
AnaptysBio | ANAB | Jan 24, 2025 | 16.85 | +1.32 |
Anavex Life Sciences | AVXL | Jan 24, 2025 | 10.49 | +2.84 |
Andretti Acquisition II | POLE | Jan 24, 2025 | 10.03 | 0.00 |
Andretti Acquisition II Unit | POLEU | Jan 24, 2025 | 10.07 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Jan 24, 2025 | 1.54 | -2.53 |
Angel Oak Financial Strategies | FINS | Jan 24, 2025 | 13.21 | +0.08 |
Angel Oak Mortgage REIT | AOMR | Jan 24, 2025 | 10.14 | +0.70 |
Anghami | ANGH | Jan 24, 2025 | 0.72 | +2.88 |
Angi A | ANGI | Jan 24, 2025 | 1.88 | +1.62 |
AngioDynamics | ANGO | Jan 24, 2025 | 12.19 | -2.09 |
Anglogold Ashanti | AU | Jan 24, 2025 | 28.23 | +0.86 |
Anheuser-Busch InBev ADR | BUD | Jan 24, 2025 | 48.87 | +1.37 |
ANI Pharmaceuticals | ANIP | Jan 24, 2025 | 58.64 | -0.09 |
Anika Therapeutics | ANIK | Jan 24, 2025 | 16.31 | -0.37 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.